Approval · Notice of Compliance 2085 · 1999
ANDROPLEX: Notice of Compliance 2085
Issued February 17, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2085
- Date
- February 17, 1999
- Company
- Smithkline Beecham Pharma, Division Of Smithkline Beecham Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Testosterone replacement therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANDROPLEX | 02239653 | Cancelled Post Market |
Medicinal ingredients
- TESTOSTERONE 12.2 MG per PAD